Download Staying 21 CFR Part 11 Compliant Using a Validated

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Big data wikipedia , lookup

Clusterpoint wikipedia , lookup

Database model wikipedia , lookup

Functional Database Model wikipedia , lookup

Transcript
Staying 21 CFR Part 11 Compliant Using a
Validated OpenClinica Environment
Patrick Murphy, Sr. Director of Data Management,
RTI-Health Solutions
1
Regulations and Guidance
 21 CFR Part 11
 Good Clinical Practices
 Guidance
©
#OC15Europe
2
21 CFR Part 11
 21 CFR Part 11: Electronic Records, Electronic Signatures
 http://www.21cfrpart11.com/files/library/government/21cfrpart11_fi
nal_rule.pdf
 “The regulations in this part set forth the criteria under which
the agency considers electronic records, electronic
signatures, and handwritten signatures executed to electronic
records to be trustworthy, reliable, and generally equivalent to
paper records and handwritten signatures executed on
paper.”
 Outlines the need/methods to validate electronic signature
systems
©
#OC15Europe
3
Good Clinical Practice
 Good Clinical Practice is an international ethical and
scientific quality standard for designing, conducting,
recording and reporting trials that involve participation of
human subjects
 http://www.fda.gov/downloads/Drugs/Guidances/ucm07312
2.pdf
 International Conference on Harmonisation of Technical
Requirements for Registration of Pharmaceuticals for
Human Use, Published May 1996
 Based on practices in the European Union, Japan,
United States, Australia, Canada, Nordic countries, and
World Health Organization
©
#OC15Europe
4
Guidance Documents
 21 CFR Part 11 Guidance
 http://www.fda.gov/downloads/RegulatoryInformation/Guidances/
UCM126953.pdf
 GCP E6 Guidance
 http://www.fda.gov/downloads/Drugs/Guidances/ucm073122.pdf
 Guidance for Industry: Computerized Systems Used In
Clinical Investigations (FDA, May 2007)
 http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegul
atoryInformation/Guidances/UCM070266.pdf
©
#OC15Europe
5
What Comprises Compliance?
 There is no “Part 11 compliance” out of the box
 Compliance is achieved with an ecosystem




Software/hardware
Installation/Validation
Training
Controlled processes/Standard Operating Procedures
(SOPs)
 Change Control
 Documentation
 “If it isn’t documented, it didn’t happen.”
©
#OC15Europe
6
Topics
 Hardware/software
 Validation of data system
 Hardware and software installation
 Functionality/performance
 Training
 Standard Operating Procedures
 Change Control
©
#OC15Europe
7
Tools
 Data Management plan (including outline)
 Design specification document (including outline)
 Study build and quality control
 User acceptance testing and documentation (including an outline of the
tests performed)
 Authorizing user access (including form)
 Data entry accuracy (single and double data entry)
 Data cleaning (rules and managing discrepancies)
 Data set creation and the use of the DataMart
 Database lock (including form)
©
#OC15Europe
8
Hardware and Software
 Software systems are typically designed and validated
for use in specified environments
 You must match your hardware/software environment to
the OpenClinica recommended environments
 Operating system
 Database system
 Web server
©
#OC15Europe
9
Validation of an OpenClinica System
 Validation Plan
 Installation Plan
 Hardware, operating system, database system, web server
 Installation Report
 Documentation that installation was successful
 Performance Testing Plan
 Requirements (functionality)
 Test Cases/Scripts
 Traceability Matrix
 Maps requirements to test cases/scripts
 Performance Testing Report
 Validation Report
©
#OC15Europe
10
GCP Connection
 5.5.3 When using electronic trial data handling
and/or remote electronic trial systems, the sponsor
should
 (a) Ensure and document that the electronic data
processing system(s) conforms to the sponsor’s
established requirements for completeness,
accuracy, reliability, and consistent intended
performance (i.e., validation).
©
#OC15Europe
11
Training
 Staff should be trained on the use of OpenClinica







Administration
Design
User access
Site setup
Data entry
Notes/flags resolution
Data extraction
 Keep the documentation of all training
©
#OC15Europe
12
GCP Connection
 5.5.1 The sponsor should utilize appropriately
qualified individuals to supervise the overall
conduct of the trial, to handle the data, to verify the
data, to conduct the statistical analyses, and to
prepare the trial reports.
©
#OC15Europe
13
Standard Operating Procedures
 GCP defines SOP:
 Detailed written instructions to achieve uniformity of the
performance of a specific function
 Purpose and benefits:




Internal training material
Meet FDA regulations
Opportunity to examine and improve processes
Promote consistency and efficiency on how work is
performed and checked across sites and studies
 Accountability
©
#OC15Europe
14
GCP Connection
 5.5.3 When using electronic trial data handling
and/or remote electronic trial systems, the sponsor
should
(b) Maintain SOPs for using these systems.
©
#OC15Europe
15
Recommended SOPs










System setup/installation
System operating manual
Validation and functionality testing
Data collection and handling (including archiving, audit
trails, risk assessment)
System maintenance and security
Change control
Data backup, recovery, and contingency plans
Alternative recording methods
Computer user training
Roles and responsibilities of sponsors, clinical sites, and
other parties
©
#OC15Europe
16
Change Control
 Once a system is validated and tested, any changes
may adversely affect the system
 Updates to software, operating system, database server,
web server
 Changes required to data entry screens/data cleaning
routines
 Evaluate the risk of the changes before they are
implemented (form)
 Make a backup of data system and data!!!!
©
#OC15Europe
17
Data Management Plan
 A document that describes how data (clinical, behavioral,
lab) will be handled during the course of the study
 Similar in nature and scope to a statistical analysis plan
or a clinical monitoring plan
 Important to plan in advance for details of data
management
 Barriers can be identified and rectified early
 Document important changes in data management so
that others can understand the process later
©
#OC15Europe
18
Data Management Plan (2)
 Needed to write DM plan:
 Study Protocol
 The study protocol defines how and why the study is being
conducted. This document is key to understanding the
study.
 Study Manual/Monitoring Plan
 CRFs
 Data coming from external sources, e.g., laboratory data
©
#OC15Europe
19
DM Plan Outline
 Data Capture
 Data Transfer of forms and external data files (e.g., labs)
 Data Transcription from Source Documents
 Data Entry/Filing
 Data Cleaning
 Data Set Creation
 Data Storage
 Data Processing
 Data System Validation
©
#OC15Europe
20
Design Specification Document
 Describes the requirements of a particular study data
system
 Approve before programming begins
 Data collection forms should be approved prior
 Discuss environment, features with study team
 Details can be used as basis for user acceptance testing
routines
©
#OC15Europe
21
Design Specification Outline
 Development and production environment
 Data forms to be programmed/naming conventions
 Audit trail commencement
 Security requirements
 Data export formats
 Data cleaning requirements
 Discrepancy resolution
©
#OC15Europe
22
Study Build and Quality Control
 Version control of Excel forms used for data entry
 Use correct Excel form
 Track each version of CRF Excel file
 Approve CRF Excel file
 Independent quality control
 Compare each field’s question text, data type, answer set,
data validations to the approved data collection form
 Maintain documentation
 Use separate environments with separate controls
 Development/testing environment (no change control)
 Production environment (change control implemented)
©
#OC15Europe
23
User Acceptance Testing and Documentation
 Systematic testing of functionality of specific data system
 Should be performed one each study
 Documentation
 Make available for audits
 If an error is found in your data system, you can investigate
how it was not identified in UAT and then modify your UAT
process
 UAT Plan describes process
 UAT Report documents results
©
#OC15Europe
24
UAT Plan Outline (1)
 Introduction
 Define scope of testing
 List features to be tested








Secure user access
Performance (especially between continents)
Comparison of data forms to data system
Entry of test data
Data cleaning checks, skip patterns, auto-fills
Extraction of test data to data sets/comparison
Reports
Audit trail
 UAT Report summarizing results of UAT
©
#OC15Europe
25
UAT Plan Outline (2)
 Test scripts
 Pre-defined steps to determine that a feature is working correctly
 A test script can test more than one feature
 Test data entry screen
 Test data cleaning program
 Traceability Matrix
 Table showing which test scripts test which features
 Ensures that all features are tested
 Define how to deal with exceptions
 Script is inaccurate
 System doesn’t function correctly
©
#OC15Europe
26
UAT Report Outline
 Introduction
 Refers to UAT plan
 Describes results of testing
 How many rounds of testing occurred
 Describes any limitations found for system
 Concludes that system is ready for use in production
environment
 Recommend to perform test data entry (e.g., a test site)
in the production area to confirm that the system is
working after migration from testing environment
©
#OC15Europe
27
Authorizing User Access
 Use a form to document and control access to your data
system
 Role setting







Data entry person
Data manager
Study director
Data specialist
Investigator
Monitor
Clinical research coordinator
©
#OC15Europe
28
User Access Form
©
#OC15Europe
29
Data Entry Accuracy
 Data entry modes
 EDC (single entry)
 Paper data entry (double entry)
 Tips:






Use pull-down lists
Use OpenClinica validations and rules
Use ranges
Display units
Hide fields until they are needed
Include ‘data not available’, ‘not applicable’ options to
ensure that all questions can be answered
 Encourage the use of notes
©
#OC15Europe
30
GCP Connection
 4.9.1 The investigator should ensure the accuracy,
completeness, legibility, and timeliness of the data
reported to the sponsor in the CRFs and in all
required reports.
 But it doesn’t say how to do it
©
#OC15Europe
31
Data Cleaning
 Discrepancies are generated when OpenClinica data
cleaning rules are violated
 Data manager should review notes and discrepancies
 Resolve or propose resolution to site
 Describe in Data Management Plan
 If a data cleaning rule/validation is creating an inordinate
number of discrepancies, consider revising the
rule/validation or retraining the sites
 Run additional quality checks in external systems (e.g.,
SAS, Excel)
©
#OC15Europe
32
Data Set Creation and the Use of
the DataMart
 OpenClinica supports many output formats for data
 Import data into the DataMart




Set up with help of OpenClinica staff
PostgreSQL database
Use SQL statements to query the data
Can establish a daily extract from OpenClinica to DataMart
 Data is in “record-oriented” format
 SAS programs link to DataMart to create SAS data sets
©
#OC15Europe
33
Database Lock
 Ensure that all expected data is entered
 Ensure that all notes and discrepancies are resolved
 Ensure that all coding of data (e.g., medical coding with
MedDRA) is complete
 Create data sets
 Remove users ‘write’ access to data system
©
#OC15Europe
34
Database Lock Form (1 of 2)
©
#OC15Europe
35
Database Lock Form (2 of 2)
©
#OC15Europe
36
Conclusion
 Regulatory compliance is a combination of the proper
hardware, software, validation, training, standard
operating procedures, change control, documentation
 Retain documentation for audits, process improvements,
and to show control over your systems
 Write a plan to implement and maintain a regulatory
compliant system – it won’t happen overnight
©
#OC15Europe
37